Abstract
Aim
The study aimed to assess the haemodynamic effects of fludrocortisone and midodrine, alone or combined, in patients with recurrent syncope and/or symptoms due to hypotension and ≥ 1 daytime systolic blood pressure (SBP) drop < 90 mmHg or ≥ 2 daytime SBP drops < 100 mmHg recorded by 24-h ambulatory blood pressure monitoring (ABPM1).
Method
A total of 53 patients (mean age, 40.9 ± 18.5 years, 37 female) were treated with fludrocortisone (0.05–0.2 mg per day) and/or midodrine (2.5–10 mg two or three times per day). A second ABPM (ABPM2) was performed within 6 months and the results of ABPM1 AND ABPM2 were compared to assess the effects of BP-rising drugs.
Results
In 32 patients assigned to fludrocortisone, 24-h SBP increased from 107.1 ± 9.9 mmHg to 116.3 ± 14.9 (p = 0.0001), the number of daily SBP drops < 90 mmHg decreased by 73% (p = 0.0001) and that of drops < 100 mmHg decreased by 41% (p = 0.0005). In 14 patients assigned to midodrine, 24-h SBP increased from 112.7 ± 7.4 mmHg to 115.0 ± 9.1 (p = 0.12), the number of daily SBP drops < 90 mmHg decreased by 52% (p = 0.04) and that of drops < 100 mmHg decreased by 34% (p = 0.007). In the seven patients taking both fludrocortisone and midodrine, 24-h SBP increased from 110.1 ± 11.5 mmHg to 114.0 ± 12.4 (p = 0.002), the number of daily SBP drops < 90 mmHg decreased by 69% (p = 0.22) and that of drops < 100 mmHg decreased by 44% (p = 0.04).
Conclusions
Both fludrocortisone and midodrine effectively increased 24-h SBP and reduced SBP drops on ABPM but fludrocortisone seemed to be more effective than midodrine. Further randomised studies are needed to confirm these observations.

Data availability
The data underlying this article are available in the article and in its online supplementary material.
References
Brignole M, Rivasi G (2021) New insights in diagnostics and therapies in syncope: a novel approach to non-cardiac syncope. Heart 107(11):864–873. https://doi.org/10.1136/heartjnl-2020-318261
Duschek S, Schandry R (2007) Reduced brain perfusion and cognitive performance due to constitutional hypotension. Clin Auton Res 17(2):69–76. https://doi.org/10.1007/s10286-006-0379-7
Rivasi G, Groppelli A, Brignole M, Soranna D, Zambon A, Bilo G et al. (2022) Association between hypotension during 24 h ambulatory blood pressure monitoring and reflex syncope: the SynABPM 1 study. Eur Heart J 43(38):3765–3776. https://doi.org/10.1093/eurheartj/ehac347
Sharad B, Rivasi G, Hamrefors V, Johansson M, Ungar A, Sutton R et al. (2023) Twenty-four-hour ambulatory blood pressure profile in patients with reflex syncope and matched controls. J Am Heart Assoc 12(8):e028704. https://doi.org/10.1161/JAHA.122.028704
Groppelli A, Rivasi G, Fedorowski A, de Lange F, Russo V, Maggi R et al. (2024) Interventions aimed to increase average 24-hour systolic blood pressure reduce blood pressure drops in patients with reflex syncope and orthostatic intolerance. Europace. https://doi.org/10.1093/europace/euae026
Brignole M, Moya A, de Lange FJ, Deharo JC, Elliott PM, Fanciulli A et al. (2018) 2018 ESC Guidelines for the diagnosis and management of syncope. Eur Heart J 39(21):1883–1948. https://doi.org/10.1093/eurheartj/ehy037
Russo V, Parente E, Tomaino M, Comune A, Sabatini A, Laezza N et al. (2023) Short-duration head-up tilt test potentiated with sublingual nitroglycerin in suspected vasovagal syncope: the fast Italian protocol. Eur Heart J 44(27):2473–2479. https://doi.org/10.1093/eurheartj/ehad322
Sheldon R, Raj SR, Rose MS, Morillo CA, Krahn AD, Medina E et al. (2016) Fludrocortisone for the prevention of vasovagal syncope: a randomized. Placebo-Controlled Trial J Am Coll Cardiol 68(1):1–9. https://doi.org/10.1016/j.jacc.2016.04.030
Sheldon R, Faris P, Tang A, Ayala-Paredes F, Guzman J, Marquez M et al. (2021) Midodrine for the prevention of vasovagal syncope : a randomized clinical trial. Ann Intern Med 174(10):1349–1356. https://doi.org/10.7326/M20-5415
Lei LY, Raj SR, Sheldon RS (2022) Midodrine for the prevention of vasovagal syncope: a systematic review and meta-analysis. Europace 24(7):1171–1178. https://doi.org/10.1093/europace/euab323
Sutton R, Brignole M (2014) Twenty-eight years of research permit reinterpretation of tilt-testing: hypotensive susceptibility rather than diagnosis. Eur Heart J 35(33):2211–2212. https://doi.org/10.1093/eurheartj/ehu255
Veazie S, Peterson K, Ansari Y, Chung KA, Gibbons CH, Raj SR et al. (2021) Fludrocortisone for orthostatic hypotension. Cochrane Database Syst Rev 5(5):CD012868
Ward CR, Gray JC, Gilroy JJ, Kenny RA (1998) Midodrine: a role in the management of neurocardiogenic syncope. Heart 79(1):45–49. https://doi.org/10.1136/hrt.79.1.45
Kaufmann H, Saadia D, Voustianiouk A (2002) Midodrine in neurally mediated syncope: a double-blind, randomized, crossover study. Ann Neurol 52(3):342–345. https://doi.org/10.1002/ana.10293
Behnoush AH, Yazdani K, Khalaji A, Tavolinejad H, Aminorroaya A, Jalali A et al. (2023) Pharmacologic prevention of recurrent vasovagal syncope: a systematic review and network meta-analysis of randomized controlled trials. Heart Rhythm 20(3):448–460. https://doi.org/10.1016/j.hrthm.2022.12.010
Acknowledgements
Research partially funded by the Italian Ministry of Health.
Funding
Agenzia Italiana del Farmaco, Ministero della Salute, NCT05729724, Michele Brignole.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests. Frederik J. de Lange, Giulia Rivasi, Antonella Groppelli, Vincenzo Russo, Roberto Maggi, Marco Capacci, Sara Nawaz, Gianfranco Parati, Michele Brignole and Artur Fedorowski this authors take responsibility for all aspects of the reliability and freedom from bias of the data presented and their discussed interpretation.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
de Lange, F.J., van Zanten, S., Rivasi, G. et al. Haemodynamic effects of fludrocortisone and midodrine in patients with symptoms due to hypotension. Clin Auton Res (2024). https://doi.org/10.1007/s10286-024-01096-3
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s10286-024-01096-3